{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:31:35Z","timestamp":1790544695854,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Despite the disease's long history, little progress has been made toward a treatment for rabies. The prognosis for patient recovery remains dire. For any prospect of survival, patients require aggressive critical care, which physicians in rabies endemic areas may be reluctant or unable to provide given the cost, clinical expertise required, and uncertain outcome. Systematic clinical research into combination therapies is further hampered by sporadic occurrence of cases. In this Perspective, we examine the case for a One Medicine approach to accelerate development of an effective therapy for rabies through the veterinary care and investigational treatment of naturally infected dogs in appropriate circumstances. We review the pathogenesis of rabies virus in humans and dogs, including recent advances in our understanding of the molecular basis for the severe neurological dysfunction. We propose that four categories of disease process need to be managed in patients: viral propagation, neuronal degeneration, inflammation and systemic compromise. Compassionate critical care and investigational treatment of naturally infected dogs receiving supportive therapy that mimics the human clinical scenario could increase opportunities to study combination therapies that address these processes, and to identify biomarkers for prognosis and therapeutic response. We discuss the safety and ethics of this approach, and introduce the Canine Rabies Treatment Initiative, a non-profit organization with the mission to apply a One Medicine approach to the investigation of diagnostic, prognostic, and therapeutic options for rabies in naturally infected dogs, to accelerate transformation of rabies into a treatable disease for all patients.<\/jats:p>","DOI":"10.3389\/fvets.2022.867382","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T08:04:37Z","timestamp":1647417877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["A One Medicine Mission for an Effective Rabies Therapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Darryn L.","family":"Knobel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund C. J.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta S.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert J.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Rivett-Carnac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Tordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Zambelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/tropicalmed2020005","article-title":"Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure","volume":"2","author":"Tarantola","year":"2017","journal-title":"Trop Med Infect Dis."},{"key":"B2","first-page":"728","volume-title":"An English Translation of the Sushruta Samhita, Based on Original Sanskrit Text by Susruta. Volume 1.","author":"Bhishagratna","year":"1907"},{"key":"B3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/B978-0-12-818705-0.00017-0","article-title":"Therapy of human rabies","volume-title":"Rabies: Scientific Basis of the Disease and Its Management","author":"Jackson","year":"2020"},{"key":"B4","article-title":"Treatment of rabies","author":"Jackson","year":"2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies [published correction appears in PLoS Negl Trop Dis","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby RE","year":"2005","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0004774","DOI":"10.1371\/journal.pntd.0004774","article-title":"Human rabies survivors in India: an emerging paradox?","volume":"10","author":"Mani","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4269\/ajtmh.18-0711","article-title":"Case reports: survival from rabies: case series from India","volume":"100","author":"Mani","year":"2019","journal-title":"Am J Trop Med Hyg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/tropicalmed2040052","article-title":"The imperative of palliation in the management of rabies encephalomyelitis","volume":"2","author":"Warrell","year":"2017","journal-title":"Trop Med Infect Dis."},{"key":"B10","unstructured":"2018"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1016\/j.vaccine.2007.08.054","article-title":"Failures of post-exposure rabies prophylaxis","volume":"25","author":"Wilde","year":"2007","journal-title":"Vaccine."},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.15585\/mmwr.mm7101a5","article-title":"Notes from the field: three human rabies deaths attributed to bat exposures\u2014United States, August 2021","volume":"71","author":"Kunkel","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1128\/jvi.75.17.8096-8104.2001","article-title":"Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders","volume":"75","author":"Badrane","year":"2001","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/v13091769","article-title":"Renewed public health threat from emerging lyssaviruses","volume":"13","author":"Fooks","year":"2021","journal-title":"Viruses."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3201\/eid2612.203592","article-title":"Lyssaviruses in insectivorous bats, South Africa, 2003-2018","volume":"26","author":"Coertse","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: changing prophylaxis and new insights in pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr Opin Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","author":"Hemachudha","year":"2002","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1086\/421556","article-title":"Survival of naturally infected rabid dogs and cats","volume":"39","author":"Tepsumethanon","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/13550280701883857","article-title":"Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies","volume":"14","author":"Laothamatas","year":"2008","journal-title":"J Neurovirol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1746-6148-9-31","article-title":"Reduced viral burden in paralytic compared to furious canine rabies is associated with prominent inflammation at the brainstem level","volume":"9","author":"Shuangshoti","year":"2013","journal-title":"BMC Vet Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"ra5","DOI":"10.1126\/scisignal.2000510","article-title":"Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein","volume":"3","author":"Pr\u00e9haud","year":"2010","journal-title":"Sci Signal."},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat Rev Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/v8080231","article-title":"Subversion of the immune response by rabies virus","volume":"8","author":"Scott","year":"2016","journal-title":"Viruses."},{"key":"B25","doi-asserted-by":"publisher","first-page":"622516","DOI":"10.3389\/fimmu.2021.622516","article-title":"Street RABV induces the cholinergic anti-inflammatory pathway in human monocyte-derived macrophages by binding to nAChr \u03b17","volume":"12","author":"Embregts","year":"2021","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0004023","DOI":"10.1371\/journal.pntd.0004023","article-title":"Differential host immune responses after infection with wild-type or lab-attenuated rabies viruses in dogs","volume":"9","author":"Gnanadurai","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1128\/JVI.01964-06","article-title":"Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection","volume":"81","author":"Roy","year":"2007","journal-title":"J Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1128\/JVI.03149-13","article-title":"Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines\/cytokines induced by rabies virus infection","volume":"88","author":"Chai","year":"2014","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1128\/JVI.01677-07","article-title":"Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice","volume":"82","author":"Scott","year":"2008","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-0-12-818705-0.00009-1","article-title":"Pathogenesis","volume-title":"Rabies: Scientific Basis of the Disease and its Management","author":"Jackson","year":"2020"},{"key":"B31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s13365-013-0214-6","article-title":"Mitochondrial dysfunction in rabies virus infection of neurons","volume":"19","author":"Alandijany","year":"2013","journal-title":"J Neurovirol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1128\/JVI.02654-09","article-title":"Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons","volume":"84","author":"Jackson","year":"2010","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1008343","DOI":"10.1371\/journal.ppat.1008343","article-title":"Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies","volume":"16","author":"Sundaramoorthy","year":"2020","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.conb.2020.02.012","article-title":"The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease","volume":"63","author":"Figley","year":"2020","journal-title":"Curr Opin Neurobiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD? destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e71148","DOI":"10.7554\/eLife.71148","article-title":"Live imaging reveals the cellular events downstream of SARM1 activation","volume":"10","author":"Ko","year":"2021","journal-title":"Elife."},{"key":"B37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s13365-016-0506-8","article-title":"Serine residues at positions 162 and 166 of the rabies virus phosphoprotein are critical for the induction of oxidative stress in rabies virus infection","volume":"23","author":"Kammouni","year":"2017","journal-title":"J Neurovirol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tins.2021.10.014","article-title":"Mitochondrial dysfunction as a trigger of programmed axon death","volume":"45","author":"Merlini","year":"2022","journal-title":"Trends Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/344905","article-title":"Management of rabies in humans","volume":"36","author":"Jackson","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1016\/j.vaccine.2018.05.066","article-title":"Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin","volume":"37","author":"Marosi","year":"2019","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2851","article-title":"Antiviral therapy for human rabies","volume":"20","author":"Appolinario","year":"2015","journal-title":"Antivir Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.20506\/rst.37.2.2832","article-title":"Antivirals for human use against rabies and prospects for their future application","volume":"37","author":"Koraka","year":"2018","journal-title":"Rev Sci Tech."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1099\/jgv.0.001269","article-title":"Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS","volume":"100","author":"Smith","year":"2019","journal-title":"J Gen Virol."},{"key":"B44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-12-801919-1.00027-0","article-title":"Rabies therapeutics: development of anti-viral approaches","author":"Castel","year":"2015","journal-title":"Current Laboratory Techniques in Rabies Diagnosis, Research and Prevention, Volume 2"},{"key":"B45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e2722","DOI":"10.1093\/cid\/ciaa779","article-title":"A Phase 3, randomized, open-label, noninferiority trial evaluating anti-rabies monoclonal antibody cocktail (TwinrabTM) against human rabies immunoglobulin (HRIG)","volume":"73","author":"Kansagra","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12628","DOI":"10.15252\/emmm.202012628","article-title":"A combination of two human monoclonal antibodies cures symptomatic rabies","volume":"12","author":"de Melo","year":"2020","journal-title":"EMBO Mol Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small molecule SARM1 inhibitors recapitulate the SARM1-\/- phenotype and allow recovery of a metastable pool of axons fated to degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13550280590900418","article-title":"The role of immune responses in the pathogenesis of rabies","volume":"11","author":"Hooper","year":"2005","journal-title":"J Neurovirol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1139\/m70-115","article-title":"The effects of corticosteroids on rabies in mice","volume":"16","author":"Enright","year":"1970","journal-title":"Can J Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1016\/j.vaccine.2017.10.098","article-title":"The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model","volume":"37","author":"Smreczak","year":"2019","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1128\/JVI.00323-07","article-title":"Therapy with minocycline aggravates experimental rabies in mice","volume":"81","author":"Jackson","year":"2007","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"761074","DOI":"10.3389\/fcimb.2021.761074","article-title":"Transcriptome profile during rabies virus infection: identification of human CXCL16 as a potential new viral target","volume":"11","author":"Feige","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12985-020-01429-4","article-title":"Inflammatory response and MAPK and NF-\u03baB pathway activation induced by natural street rabies virus infection in the brain tissues of dogs and humans","volume":"17","author":"Liu","year":"2020","journal-title":"Virol J."},{"key":"B56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-818705-0.00008-X","article-title":"Human disease","volume-title":"Rabies: Scientific Basis of the Disease and its Management, Fourth Edition","author":"Jackson","year":"2020"},{"key":"B57","first-page":"945","article-title":"Extraneural organ involvement in human rabies","volume":"79","author":"Jackson","year":"1999","journal-title":"Lab Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tips.2020.01.006","article-title":"Axons Matter: The promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration","volume":"41","author":"Krauss","year":"2020","journal-title":"Trends Pharmacol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"783140","DOI":"10.3389\/fcimb.2021.783140","article-title":"Machine learning identifies cellular and exosomal microRNA signatures of lyssavirus infection in human stem cell-derived neurons","volume":"11","author":"Farr","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"key":"B61","volume-title":"Laboratory Techniques in Rabies, Volume 1, 5th Edition.","year":"2018"},{"key":"B62","unstructured":""}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.867382\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T08:04:46Z","timestamp":1647417886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.867382\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":62,"alternative-id":["10.3389\/fvets.2022.867382"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.867382","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"article-number":"867382"}}